Michal Amit Rahat

7PUBLICATIONS
10CO-AUTHORS
MechanobiologyHaematological tumoursMajor global burdens of diseasePredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Dec 30, 2025
The Anti-EMMPRIN Monoclonal Antibody hMR18-mAb Induces Tumor Dormancy and Inhibits the EMT Process in Human Carcinoma Cell Lines Co-Cultured with Macrophages.

Elina Simanovich, Felix Oyelami, Phillipp Brockmeyer

|Jul 13, 2024
Tofacitinib Regulates Endostatin via Effects on CD147 and Cathepsin S.

Devy Zisman, Hala Sabtan, Maya M Rahat

|Apr 27, 2024
Glucose Promotes EMMPRIN/CD147 and the Secretion of Pro-Angiogenic Factors in a Co-Culture System of Endothelial Cells and Monocytes.

Fransis Ghandour, Sameer Kassem, Elina Simanovich

|Oct 28, 2023
Combined Biomarker System Predicts Prognosis in Patients with Metastatic Oral Squamous Cell Carcinoma.

Tatjana Khromov, Lucas Fischer, Andreas Leha

|Mar 29, 2023
Knocking-Down CD147/EMMPRIN Expression in CT26 Colon Carcinoma Forces the Cells into Cellular and Angiogenic Dormancy That Can Be Reversed by Interactions with Macrophages.

Gabriele Feigelman, Elina Simanovich, Phillipp Brockmeyer

|Nov 18, 2020
Inducing regulated necrosis and shifting macrophage polarization with anti-EMMPRIN antibody (161-pAb) and complement factors.

Nizar Hijaze, Max Ledersnaider, Elina Simanovich

Pageof 2

Frequent Collaborators

3 joint publications

Phillipp Brockmeyer

1 joint publications

Amedeo Amedei

1 joint publications

Fransis Ghandour

1 joint publications

Hala Sabtan